It also showed that for PCOS patients and couples with poor response, the GnRH-ant regimen can reduce the occurrence of OHSS without reducing clinical pregnancy rates and can be considered the standard treatment for PCOS patients. The gene discussed is GNRH1; the disease is polycystic ovary syndrome.